Lukas Stejskal

Haematology/Tranfusiology Department, Silesian Hospital Opava, Opava, Czech Republic, Czech Republic

Poster(s):

• 1526 - Ibrutinib and acalabrutinib in the treatment of relapsed/refractory chronic lymphocytic leukemia: a real-world analysis from the Czech Chronic Lymphocytic Leukemia Patients Registry